Bilirubin

• 

  Subject Areas on Research

  • A GWAS Study on Liver Function Test Using eMERGE Network Participants. 
  • A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients. 
  • A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. 
  • A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation. 
  • Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series. 
  • Acute pancreatitis and fulminant hepatic failure. 
  • Aggressive vs. conservative phototherapy for infants with extremely low birth weight. 
  • Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation. 
  • Alterations in reticulo-endothelial functions as produced by the administration of bacterial toxins. 
  • Amoxicillin-Clavulanate-Induced Liver Injury. 
  • Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation. 
  • Association between bilirubin and mode of death in severe systolic heart failure. 
  • Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers. 
  • Brainstem bilirubin toxicity in the newborn primate may be promoted and reversed by modulating PCO2. 
  • Cardiohepatic interactions in heart failure: an overview and clinical implications. 
  • Children's liver chemistries vary with age and gender and require customized pediatric reference ranges. 
  • Cholecystokinin is not a peripheral satiety signal in the dog. 
  • Clinical and physiological abnormalities in hepatic function. 
  • Clinical laboratory evaluation of the American optical Bilirubinometer. 
  • Clinical manifestations of congenital syphilitic hepatitis: implications for pathogenesis. 
  • Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry. 
  • Comparison of Transcutaneous and Serum Bilirubin Measurements in Neonates 30 to 34 Weeks' Gestation Before, During, and After Phototherapy. 
  • Cross circulation between children in hepatic coma and chimpanzees. Clinical, biochemical, and coagulation observations. 
  • Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. 
  • Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. 
  • Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. 
  • Eccrine Chromhidrosis in an Adolescent with Sickle Cell Disease. 
  • Effect of bilirubin UDP glucuronosyltransferase 1 gene TATA box genotypes on serum bilirubin concentrations in chronic liver injuries. 
  • Effect of cyclosporine on bile secretion in rats. 
  • Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. 
  • Effect of hepatic artery flow on bile secretory function after cold ischemia. 
  • Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI. 
  • Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis. 
  • Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia. 
  • Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial. 
  • Hospital change to mixed lipid emulsion from soybean oil-based lipid emulsion for parenteral nutrition in hospitalized and critically ill adults improves outcomes: a pre-post-comparative study. 
  • Hypercalcemia. A complication of advanced chronic liver disease. 
  • Hypotensive effects of clonidine and chlorthalidone. Controlled clinical trial of drugs administered singly and in combination. 
  • Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF). 
  • Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury. 
  • Insignificant blood damage in calves with a total artificial heart up to six months. 
  • Interactions of vasoactive intestinal polypeptide and cholecystokinin octapeptide on the control of gallbladder contraction. 
  • Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. 
  • Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. 
  • Long-term follow-up of auxiliary orthotopic liver transplantation for the treatment of fulminant hepatic failure. 
  • MELD-Na Accurately Predicts 6-Month Mortality in Patients With Decompensated Cirrhosis: Potential Trigger for Hospice Referral. 
  • Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. 
  • Mechanical property studies of human gallstones. 
  • Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome. 
  • Methylphenidate-induced autoimmune hepatitis. 
  • Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. 
  • Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. 
  • Partial splenectomy for hereditary spherocytosis: a multi-institutional review. 
  • Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitor. 
  • Physiological correlates of HIV-related fatigue. 
  • Population Pharmacokinetics of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: An Integrated Analysis. 
  • Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. 
  • Pretransplant status and patient survival following liver transplantation. 
  • Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort. 
  • Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients. 
  • Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. 
  • Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. 
  • Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. 
  • Protective response of the Ah receptor to ANIT-induced biliary epithelial cell toxicity in see-through medaka. 
  • Remodelling of the Vibrio cholerae membrane by incorporation of exogenous fatty acids from host and aquatic environments. 
  • Repeat surgical bowel lengthening with the STEP procedure. 
  • Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I). 
  • Serum hepatic enzyme and bilirubin elevations during parenteral nutrition. 
  • Severe cholestasis related to intraconazole for the treatment of onychomycosis. 
  • Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. 
  • Surgical portosystemic shunts for treatment of portal hypertensive bleeding: outcome and effect on liver function. 
  • The effects of hepatic cryosurgery on tumor growth in the liver. 
  • The laboratory method as a variable in the interpretation of serum bilirubin fractionation. 
  • The relationship between hepatitis B surface antigen and antibody and continued drug use in narcotic dependency: a randomized controlled study. 
  • Transient abnormalities in serum bilirubin and lactate dehydrogenase levels following red blood cell transfusions in adults. 
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? 
  • Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver. 
• 

  Keywords of People

  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology